Association of Thrombotic and Fibrinolytic Factors with Severity of Culprit Lesion in Patients with Acute Coronary Syndromes Without ST Elevation
Background: Increased procoagulant activity and/or impaired fibrinolysis contribute to the development and organization of thrombus, subsequently resulting in complete or incomplete obstruction in acute coronary syndromes (ACS). We investigated the relationship between culprit lesion severity and thrombotic and fibrinolytic parameters in patients who had non-ST elevation ACS (NSTE-ACS).
Methods: This study included 95 consecutive patients with NSTE-ACS. All patients underwent coronary angiography within the first 72 hours depending on the clinical situation. Stenosis ≥50% in the coronary artery was considered significant. NSTE-ACS patients were then divided into two groups: patients with critical stenosis (n = 53) and patients with noncritical stenosis (n = 35). Plasma levels of D-dimer, fibrinogen, thrombin-antithrombin III complex (TAT), and prothrombin fragment 1 + 2 (PF 1 + 2) were measured.
Results: D-dimer (338 ± 192 vs. 190 ± 170 μg/dL, P < 0.001), TAT (4.4 ± 2.0 vs. 1.2 ± 0.7 ng/mL, P < 0.001), and PF 1 + 2 (1.6 ± 0.6 vs. 0.7 ± 0.3 nmol/L) levels were significantly higher in the critical stenosis group as compared to the noncritical stenosis group. However, fibrinogen levels were similar in both groups. The levels of TAT (r = 0.76, P < 0.001) and PF 1 + 2 (r = 0.73, P < 0.001) were correlated with the culprit lesion severity, but D-dimer and fibrinogen levels were not. Thrombolysis in myocardial infarction flow grades were also correlated with TAT (r = −0.42, P < 0.001) and PF 1 + 2 (r = −0.40, P < 0.001).
Conclusion: The severity of culprit lesion may be associated with plasma D-dimer, TAT, and PF 1 + 2 levels in NSTE-ACS patients. These prothrombotic factors may have a role in the development of significant stenosis in the NSTE-ACS setting.
* Thrombotic and fibrinolytic systems have a critical role in acute coronary syndrome (ACS) pathophysiology.
* Previous data have shown the critical impact of elevated procoagulant activity or impaired fibrinolysis in patients with ACS on thrombus organization or complete lumen occlusion.
* Thrombin-antithrombin III complex (TAT) and prothrombin fragment (PF) 1 + 2 levels reflect thrombin generation and its activity.
* TAT and PF 1 + 2 assays may be beneficial in determining ACS patients at high risk.
* D-dimer, TAT, and PF 1 + 2 levels may have a role in the development of significant stenosis in the ACS setting.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.